This section contains two parts. The first part includes references to documents, related weblinks and existing toolkits regarding behavioural surveillance methodology and evaluation methods in the HIV/AIDS field.
In the context of the ongoing outbreak of Shiga toxin-producing E. coli (STEC) that affects by now citizens from 13 EU member states, it is crucial not only to align the efforts regarding investigation and control of the outbreak but also to share knowledge among practitioners across Europe on the patho-physiological and clinical characteristics of infection caused by this unusual epidemic strain, and review patient management options.
On 9 June, ECDC will be hosting a technical side-event to the United Nations High-Level Meeting on AIDS 2011. The event will highlight how countries and regions with differing epidemiology could improve their responses to HIV/AIDS.
Today, the German authorities published a press release on the current Shiga toxin-producing E.coli outbreak. In their joint statement they recommended in particular to abstain from eating raw sprouts.
ECDC Director Marc Sprenger at the European Parliament Committee on the Environment, Public Health and Food Safety (ENVI) stressed the importance of the EU’s continuous commitment in the fight against hepatitis B and hepatitis C.
In September 2010, two cases of autochthonous dengue fever were diagnosed in metropolitan France for the first time. The cases occurred in Nice, southeast France, where the vector Aedes albopictus is established.
Aedes aegypti is a highly specialized mosquito species feeding predominantly on humans and breeding in artificial water holding containers in urban areas, and currently restricted to subtropical and tropical areas. Williams et al. focus on the reasons why Ae. aegypti once occurred in locations where the mosquito does not occur anymore in Australia, the more temperate drier parts of the country.
The first annual meeting of the European hepatitis B and C surveillance network takes place on 23-24 March 2011. Since 2009, ECDC has worked on preparing the enhanced surveillance of hepatitis B and C at EU/EEA level by establishing a network for hepatitis B and C surveillance and by carrying out a survey on prevention and surveillance activities in the Member States.